Gut
Published human trials in gut conditions, including irritable bowel syndrome.
This page lists published studies. It reports what the authors did and found, with the limits of each study. It is not advice.
7 studies listed, newest first.
- Palmitoylethanolamide supplementation for human health: A state-of-the-art systematic review of Randomized Controlled Trials in patient populationsReviewHumans
- Effect of Palmitoylethanolamide Compared to a Placebo on the Gut Microbiome and Biochemistry in an Overweight Adult Population: A Randomised, Placebo Controlled, Double-Blind StudyRandomised controlled trialHumans
- Palmitoylethanolamide and polydatin in pediatric irritable bowel syndrome: A multicentric randomized controlled trialRandomised controlled trialHumansWith polydatin
- Impaired Duodenal Palmitoylethanolamide Release Underlies Acid-Induced Mast Cell Activation in Functional DyspepsiaLaboratory studyHumansOther animals
- Palmitoylethanolamide and Cannabidiol Prevent Inflammation-induced Hyperpermeability of the Human Gut In Vitro and In Vivo: A Randomized, Placebo-controlled, Double-blind Controlled TrialRandomised controlled trialHumans
- Cannabidiol and palmitoylethanolamide are anti-inflammatory in the acutely inflamed human colonLaboratory studyHumans
- Randomised clinical trial: the analgesic properties of dietary supplementation with palmitoylethanolamide and polydatin in irritable bowel syndromeRandomised controlled trialHumansWith polydatin